BACKGROUND/AIMS Bacteremia following endoscopic retrograde cholangiopancreatography (ERCP) is a severe complication, but the risk factors for this condition have not yet been clearly determined. Thus, the aim of this study was to investigate the risk factors of post-ERCP bacteremia. METHODS Among patients who underwent ERCP from June 2006 to May 2009, we selected patients without any signs of...

BACKGROUND The aim was to study the role of rectal diclofenac in prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and its impact on severity of post-ERCP pancreatitis. METHODS We conducted a single-center, prospective, open-labeled, randomized trial for evaluating the use of rectal diclofenac in prevention of post-ERCP pancreatitis in high-risk patients. W...

BACKGROUND Cholestatic jaundice (CJ) in patients with sickle cell disease (SCD) poses diagnostic and therapeutic dilemmas. This is an evaluation of the role of ERCP in SCD. METHODS A total of 224 SCD patients with CJ had ERCP. The indications for ERCP were based on clinical and biochemical evidence of CJ and ultrasound findings. RESULTS The indications were: CJ only in79, CJ and dilated duc...

BACKGROUND/AIMS Performing endoscopic retrograde cholangiopancreatography (ERCP) in patients who have undergone Rouxen-Y gastric bypass (RYGB) is challenging. Standard ERCP and enteroscopy-assisted ERCP are associated with limited success rates. Laparoscopy- or laparotomy-assisted ERCP yields improved efficacy rates, but with higher complication rates and costs. We present the first multicenter...

BACKGROUND Most large published series on endoscopic retrograde cholangiopancreatography (ERCP) are multicentre-based and consequently reflect varying experience. AIMS To assess morbidity and mortality rates of ERCP in a single tertiary referral centre. METHODS A series of 1,758 consecutive ERCPs performed in 1,148 patients between 1991 and 1994 were reviewed to evaluate indications, findin...

Endoscopic retrograde cholangiopancreatography (ERCP) has become an effective and safe therapeutic method, providing clinical success in more than 80% of cases. As ERCP has evolved from a diagnostic to a therapeutic procedure, technical demands have risen. Furthermore, it is an invasive procedure that can be potentially harmful when administered improperly. Quality of ERCP and procedural outcom...

OBJECTIVE To determine utilisation of endoscopic retrograde cholangiopancreatography (ERCP); incidence of inpatient admissions for complications occurring within 30 days of ERCP and risk factors for procedural-related complications, in a population-based study. DESIGN Retrospective cohort study. SETTING Olmsted County, Minnesota. PARTICIPANTS All adult residents of Olmsted County, Minneso...

The aim of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Working Group was to examine the issues of training, credentialing and quality control in ERCP in Singapore. Published guidelines and clinical trials concerning issues of training, complications and quality control in ERCP have been reviewed. The Working Group recommended that a trainee reach a minimum threshold of 200 cases b...

BACKGROUND/AIMS Endoscopic retrograde cholangiopancreatography (ERCP) is considered a high-risk procedure in patients with previous acute coronary syndrome (ACS); however, clinical studies are rare in the literature. The aim of this study was to investigate the safety and efficacy of ERCP in patients with previous ACS. METHODS We retrospectively reviewed the medical records of patients with p...

Background: Acute pancreatitis is one of the most serious complications of ERCP. Early diagnosis of post ERCP pancreatitis helps physicians to provide intensive care and possible medical treatment as early as possible. Trypsinogen-2 in urine is a good diagnostic and prognostic marker of acute pancreatitis. Objectives: To evaluate the diagnostic value of urinary trypsinogen-2 dipstick test for e...